For laboratory research use only.
Delta sleep-inducing peptide (DSIP) is a short nonapeptide that entered twentieth-century neurobiology through sleep- and stress-physiology research. Its modern catalog presence is real; its mechanistic story is more heterogeneous than that of ligands with a single cloned-receptor narrative.
A specialized historical niche
Unlike GHS-R1a ligands or melanocortin agonists, DSIP does not rest on one tidy contemporary receptor monograph. Older and newer experimental papers explore sleep-related, stress-related, and neuroprotection-adjacent endpoints with mixed convergence. That heterogeneity is a reason to cite primary methods carefully rather than rely on secondary slogans.
Recent experimental reports
In rats subjected to focal stroke, DSIP administration was reported to recover motor function in the study’s behavioral assays (DSIP after focal stroke). A phosphorylated DSIP variant restored spatial memory and p-CREB-related readouts in a model of cognitive impairment (phosphorylated DSIP memory study). Separate work examined DSIP effects on hepatocyte functional state during restraint stress (DSIP hepatocytes under restraint stress). These are model-specific findings; they do not establish clinical indications.
Neighboring neuropeptides
Semax, Selank, and oxytocin are also short CNS-relevant peptides but with different parent sequences and denser modern receptor or neurotrophic literatures. Filing DSIP under those names because all can be called “neuropeptides” creates avoidable confusion.
Sources
- Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke. (Molecules, 2021, PMID 34500605)
- Phosphorylated delta sleep inducing peptide restores spatial memory and p-CREB expression by improving sleep architecture at high altitude. (Life Sci, 2018, PMID 30107169)
- Effect of Delta Sleep-Inducing Peptide on Functional State of Hepatocytes in Rats During Restraint Stress. (Bull Exp Biol Med, 2016, PMID 26902351)